TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Mouth Ulcers Drugs market was valued at US$ 1655.6 million in 2022 and is projected to reach US$ 2125.9 million by 2029, at a CAGR of 3.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers aren?t contagious and usually go away within one to two weeks. Most ulcers will heal completely without any intervention. Treatment can range from simply smoothing or removing a local cause of trauma, to addressing underlying factors such as dry mouth or substituting a problem medication. Maintaining good oral hygiene and use of an antiseptic mouthwash or spray can prevent secondary infection and therefore hasten healing. A topical analgesic may reduce pain. Topical (gels, creams or inhalers) or systemic steroids may be used to reduce inflammation. An antifungal drug may be used to prevent oral candidiasis developing in those who use prolonged steroids In this report, the mouth ulcers treatment drugs include mouthwash, gel, spray, and lozenge. The drug classes in this market are corticosteroid, anesthetic, analgesic, antihistamine, and antimicrobial.
This report aims to provide a comprehensive presentation of the global market for Mouth Ulcers Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mouth Ulcers Drugs. This report contains market size and forecasts of Mouth Ulcers Drugs in global, including the following market information:
Global Mouth Ulcer Treatment Drug key players include Colgate-Palmolive, Pfizer, GlaxoSmithKline, 3M Healthcare, Sannova, etc. Global top five manufacturers hold a share about 40%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Gel is the largest segment, with a share about 65%. And in terms of application, the largest application is Drugstores, followed by Clinics, Hospitals, etc.
We surveyed the Mouth Ulcers Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mouth Ulcers Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Mouth Ulcers Drugs Market Segment Percentages, by Type, 2022 (%)
Global Mouth Ulcers Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Mouth Ulcers Drugs Market Segment Percentages, by Application, 2022 (%)
Global Mouth Ulcers Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Mouth Ulcers Drugs Market Segment Percentages, By Region and Country, 2022 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mouth Ulcers Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Mouth Ulcers Drugs revenues share in global market, 2022 (%)
Key companies Mouth Ulcers Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Mouth Ulcers Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Outline of Major Chapters: